OPTIMOX1 in Chinese mCRC Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2015

Conditions
Colorectal Cancer
Interventions
DRUG

Oxaliplatin, LV, 5-FU

"Arm B(Intervention arm) will receive FOLFOX4 for 6 cycles, maintenance with 5FU/LV for 12 cycles, and reintroduction of FOLFOX4 for 6 cycles.~FOLFOX4 regimen:~OXA 85mg/m2 , 2 hour infusion, d1 , Leucovorin 200 mg/m2 plus 5-FU 400mg IV bolus, then continuous 22 hour 600 mg/m2 infusion on day 1 and 2 Q2W"

Trial Locations (2)

210029

RECRUITING

The 1st Affiliated Hospital Of NanJing Medical University, Nanjing

310016

RECRUITING

Zhejiang University affiliated sir run run shaw hospital, Hangzhou

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER